Biotricity Inc Quick Ratio (BTCY) starting from the third quarter 2025 to third quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Biotricity Inc   (BTCY)

Biotricity Inc 's Quick Ratio

BTCY's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Biotricity Inc 's Cash & cash equivalent grew by 20.94 % in the Q3 2025 sequentially, faster than Current Liabilities, this led to improvement in Biotricity Inc 's Quick Ratio to 0.06, Quick Ratio remained below Biotricity Inc average.

Within Medical Equipment & Supplies industry 50 other companies have achieved higher Quick Ratio than Biotricity Inc in third quarter 2025. While Quick Ratio total ranking has improved so far during the Q3 2025 to 1243, from total ranking in the second quarter 2025 at 3292.

Explain Quick Ratio?
How much Cash & cash equivalents BTCY´s has?
What are BTCY´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/BTCY/financial-strength
https://api.csimarket.com/api/v1/companies/BTCY/fundamentals
https://api.csimarket.com/api/v1/companies/BTCY/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
BTCY Quick Ratio (Dec 31 2025)
Q3
(Sep 30 2025)
Q2
(Jun 30 2025)
Q1
(Mar 31 2025)
Q4
(Dec 31 2024)
Q3
Y / Y Current Liabilities Change 12.56 %
Y / Y Cash & cash equivalent Change -30.51 %
Quick Ratio MRQ 0.06
BTCY's Total Ranking # 1243
Seq. Current Liabilities Change 0.77 %
Seq. Cash & cash equivalent Change 20.94 %



Quick Ratio third quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 51
Healthcare Sector # 170
Overall Market # 1243


Quick Ratio Statistics
High Average Low
3.99 0.51 0.01
(Dec 31 2017)   (Dec 31 2015)




Financial Statements
Biotricity Inc 's Current Liabilities $ 24 Millions Visit BTCY's Balance sheet
Biotricity Inc 's Cash & cash equivalent $ 1 Millions Visit BTCY's Balance sheet
Source of BTCY's Sales Visit BTCY's Sales by Geography


Cumulative Biotricity Inc 's Quick Ratio

BTCY's Quick Ratio for the trailling 12 Months

BTCY Quick Ratio

(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
(Mar 31 2025)
12 Months
(Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth -0.59 %
Y / Y Cash & cash equivalent TTM Growth 20.64 %
Quick Ratio TTM 0.06
Total Ranking TTM # 4548
Seq. Current Liabilities TTM Growth 3.05 %
Seq. Cash & cash equivalent TTM Growth -10.18 %


On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2025 to $23.80 millions, cumulative Quick Ratio decreased to 0.06 below the Biotricity Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 225 other companies have achieved higher Quick Ratio than Biotricity Inc . While Quick Ratio overall ranking has improved so far to 3164, from total ranking during the twelve months ending second quarter 2025 at 3331.

Explain Quick Ratio?
How much Cash & cash equivalents BTCY´s has?
What are BTCY´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 226
Healthcare Sector # 1013
Within the Market #


trailing twelve months Quick Ratio Statistics
High Average Low
1.81 0.32 0.02
(Dec 31 2022)   (Dec 31 2025)




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Medical Equipment & Supplies Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Infusystem Holdings Inc  0.16 $ 3.186  Millions$ 20.182  Millions
Stevanato Group S p a   0.15 $ 153.276  Millions$ 1,001.452  Millions
Allurion Technologies Inc   0.14 $ 5.412  Millions$ 38.445  Millions
Stimcell Energetics Inc   0.14 $ 0.046  Millions$ 0.339  Millions
Escalon Medical Corp   0.13 $ 0.337  Millions$ 2.603  Millions
Ss Innovations International Inc  0.12 $ 3.206  Millions$ 26.242  Millions
Bellevue Life Sciences Acquisition Corp  0.12 $ 1.700  Millions$ 14.127  Millions
The Pennant Group Inc   0.12 $ 17.024  Millions$ 147.264  Millions
Baird Medical Investment Holdings Limited  0.11 $ 0.859  Millions$ 7.539  Millions
Vivos Therapeutics Inc   0.11 $ 2.029  Millions$ 18.076  Millions
Pavmed Inc   0.11 $ 1.538  Millions$ 14.264  Millions
Northview Acquisition Corp  0.11 $ 1.778  Millions$ 16.525  Millions
Nexgel Inc   0.11 $ 0.317  Millions$ 2.956  Millions
Nakamoto Inc   0.10 $ 21.070  Millions$ 215.162  Millions
National Vision Holdings Inc   0.09 $ 38.708  Millions$ 412.408  Millions
Precision Optics Corporation Inc   0.09 $ 0.881  Millions$ 9.951  Millions
Becton Dickinson And Company  0.09 $ 751.000  Millions$ 8,761.000  Millions
The Cooper Companies Inc   0.08 $ 124.900  Millions$ 1,595.700  Millions
Integer Holdings Corporation  0.08 $ 17.161  Millions$ 222.942  Millions
Euda Health Holdings Limited  0.07 $ 0.345  Millions$ 5.101  Millions
Biotricity Inc   0.06 $ 1.428  Millions$ 23.797  Millions
Enovis Corp  0.06 $ 36.389  Millions$ 625.652  Millions
Odyssey Health Inc   0.05 $ 0.616  Millions$ 11.317  Millions
Agape Atp Corporation  0.05 $ 0.140  Millions$ 2.732  Millions
P3 Health Partners Inc   0.05 $ 25.012  Millions$ 503.219  Millions
Henry Schein Inc   0.05 $ 156.000  Millions$ 3,150.000  Millions
Dror Ortho-Design, Inc.  0.04 $ 0.080  Millions$ 2.267  Millions
Mountain Crest Acquisition Corp V  0.03 $ 0.012  Millions$ 0.353  Millions
Catheter Precision Inc   0.02 $ 0.088  Millions$ 3.907  Millions
Vycor Medical Inc   0.02 $ 0.093  Millions$ 4.782  Millions

Date modified: 2026-10-05T11:03:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.